Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Researchers develop CRISPR/Cas9 hemophilia A murine model

July 11, 2019

Phase I/II data presented for BIVV-001 in hemophilia A

July 10, 2019

Shanghai Meiyue Biotech presents new thrombin inhibitors

July 2, 2019

BioCryst opens enrollment in phase I study of oral factor D inhibitor BCX-9930

June 28, 2019

FDA approves Doptelet for chronic immune thrombocytopenia

June 28, 2019

EC grants marketing authorization for Doptelet for severe thrombocytopenia in adults with CLD

June 26, 2019

European Commission approves Esperoct for adolescents and adults with hemophilia A

June 21, 2019

Ultomiris approved in Japan for PNH

June 19, 2019

PB-2452 reverses ticagrelor antiplatelet activity in older and elderly patients in phase IIa trial

June 18, 2019

Luspatercept MOA: Up for grabs?

June 18, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.